Oliver H Krämer Selected Research

Oliver H Krämer Research Topics

Disease

46	Neoplasms (Cancer) 04/2024 - 07/2003
10	Leukemia 01/2022 - 05/2008
7	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 06/2010
6	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 01/2007
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2012
5	Adenocarcinoma 04/2024 - 06/2010
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2011
4	Carcinogenesis 03/2015 - 01/2007
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2024 - 01/2021
3	Inflammation (Inflammations) 01/2018 - 07/2012
3	Acute Promyelocytic Leukemia 01/2018 - 01/2012
2	Brain Neoplasms (Brain Tumor) 10/2023 - 08/2017
2	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 10/2015
2	Colonic Neoplasms (Colon Cancer) 10/2023 - 01/2019
2	Breast Neoplasms (Breast Cancer) 02/2020 - 01/2019
2	Wilms Tumor (Wilm's Tumor) 09/2019 - 01/2018
2	Lung Neoplasms (Lung Cancer) 12/2017 - 05/2014
2	Glioma (Gliomas) 08/2017 - 10/2015
1	Microsatellite Instability 10/2023
1	Hematologic Neoplasms (Hematological Malignancy) 07/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2021
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2021
1	Fibrosarcoma 01/2021
1	Triple Negative Breast Neoplasms 01/2019
1	Rectal Neoplasms (Rectal Cancer) 11/2018
1	Neuroendocrine Carcinoma 09/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Disease Progression 01/2018
1	Multiple Myeloma 01/2018
1	HIV Infections (HIV Infection) 01/2018

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2008
13	Histone Deacetylases (Histone Deacetylase)IBA 07/2023 - 07/2003
9	Histone Deacetylase InhibitorsIBA 01/2022 - 05/2008
9	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2011
8	Phosphotransferases (Kinase)IBA 01/2024 - 05/2014
5	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 05/2014
5	Hydroxyurea (Hydrea)FDA LinkGeneric 07/2021 - 01/2012
4	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 02/2020
4	entinostat (MS 275)IBA 12/2021 - 11/2016
4	SurvivinIBA 06/2018 - 01/2007
3	Histones (Histone)IBA 10/2023 - 01/2009
3	Irinotecan (Camptosar)FDA LinkGeneric 07/2022 - 06/2018
3	UbiquitinIBA 12/2020 - 10/2012
3	Valproic Acid (Depakote)FDA LinkGeneric 02/2020 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 11/2018 - 09/2018
3	Histone Deacetylase 2IBA 12/2014 - 12/2009
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2022 - 10/2015
2	marbostat-100IBA 01/2022 - 01/2018
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 01/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2020 - 11/2012
2	CytokinesIBA 02/2020 - 12/2009
2	PanobinostatIBA 01/2018 - 11/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017 - 03/2015
2	NimustineIBA 08/2017 - 10/2015
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2017 - 01/2012
2	Bcl-2-Like Protein 11IBA 10/2015 - 01/2012
2	Vorinostat FDA Link 09/2012 - 04/2012
1	Protein AggregatesIBA 04/2024
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2024
1	Proteolysis Targeting ChimeraIBA 01/2024
1	Lysine (L-Lysine)FDA Link 10/2023
1	Fluorouracil (Carac)FDA LinkGeneric 10/2023
1	NucleotidesIBA 10/2023
1	Retinal Pigments (Pigments, Visual)IBA 07/2023
1	Hydroxamic Acids (Hydroxamic Acid)IBA 07/2023
1	Janus KinasesIBA 01/2023
1	CarbamatesIBA 01/2022
1	Cyclin-Dependent Kinase Inhibitor p21IBA 01/2022
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2022
1	TubulinIBA 01/2022
1	Histone Deacetylase 6IBA 01/2022
1	Heme (Haem)IBA 01/2021
1	venetoclaxIBA 01/2021
1	RG7388IBA 01/2021
1	Bendamustine Hydrochloride FDA Link 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2020
1	fms-Like Tyrosine Kinase 3IBA 05/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2020
1	Cisplatin (Platino)FDA LinkGeneric 02/2020
1	CateninsIBA 09/2019
1	Caspase 8 (Caspase-8)IBA 01/2019
1	Culture MediaIBA 01/2019
1	Epithelial Cell Adhesion MoleculeIBA 11/2018
1	VimentinIBA 11/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2018
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2018
1	pirfenidoneIBA 01/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Collagen Type II (Type II Collagen)IBA 01/2018
1	CaspasesIBA 01/2018

Therapy/Procedure

14	Therapeutics 07/2022 - 07/2003
7	Drug Therapy (Chemotherapy) 07/2022 - 05/2014
1	Heterologous Transplantation (Xenotransplantation) 11/2018